Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 74,000 | 1,204,000 | 1,149,000 | 667,000 | 244,000 |
| Depreciation Amortization | 29,000 | 71,000 | 50,000 | 32,000 | 16,000 |
| Accounts receivable | 158,000 | -166,000 | -124,000 | -77,000 | 124,000 |
| Other Working Capital | -113,000 | 225,000 | -28,000 | -30,000 | 75,000 |
| Other Operating Activity | -145,000 | -148,000 | -162,000 | -243,000 | -172,000 |
| Operating Cash Flow | $3,000 | $1,186,000 | $885,000 | $349,000 | $287,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,631,000 | -26,000 | 26,000 | -12,000 |
| PPE Investments | -5,000 | -7,215,000 | 0 | 0 | -12,000 |
| Purchase Of Investment | -4,000 | -4,000 | -3,000 | -3,000 | -1,000 |
| Purchase Sale Intangibles | N/A | -55,000 | -42,000 | -40,000 | -18,000 |
| Other Investing Activity | 0 | -55,000 | -42,000 | -40,000 | -18,000 |
| Investing Cash Flow | $-9,000 | $-5,643,000 | $-71,000 | $-17,000 | $-43,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,500,000 | N/A | N/A | N/A |
| Debt Repayment | -63,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,000 | 23,000 | 16,000 | 7,000 | 1,000 |
| Common Stock Repurchased | -96,000 | -430,000 | -430,000 | -406,000 | N/A |
| Other Financing Activity | -20,000 | -304,000 | -26,000 | -20,000 | -14,000 |
| Financing Cash Flow | $-177,000 | $4,789,000 | $-440,000 | $-419,000 | $-13,000 |
| Exchange Rate Effect | -11,000 | 3,000 | 7,000 | 3,000 | 8,000 |
| Beginning Cash Position | 1,715,000 | 1,380,000 | 1,380,000 | 1,380,000 | 1,380,000 |
| End Cash Position | 1,521,000 | 1,715,000 | 1,761,000 | 1,296,000 | 1,619,000 |
| Net Cash Flow | $-194,000 | $335,000 | $381,000 | $-84,000 | $239,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,000 | 1,186,000 | 885,000 | 349,000 | 287,000 |
| Capital Expenditure | -5,000 | -7,215,000 | N/A | N/A | -12,000 |
| Free Cash Flow | -2,000 | -6,029,000 | 885,000 | 349,000 | 275,000 |